Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy

HPB

Volumn 12, Issue 6, 2010, Pages 396-402

  Sharif, Amar W ^a,c   Williams, Horace R T ^a   Lampejo, Temi ^a   Khan, Shahid A ^a   Bansi, Devinder S ^a   Westaby, David ^a   Thillainayagam, Andrew V ^a   Thomas, Howard C ^a   Cox, I Jane ^b   Taylor Robinson, Simon D ^a  

^a Hepatology and Gastroenterology Section   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Bile acids; Cholangiocarcinoma; Magnetic resonance spectroscopy; Mmetabonomic; Phosphatidylcholine

Indexed keywords

BILE ACID CONJUGATE; BIOLOGICAL MARKER; GLYCINE; PHOSPHATIDYLCHOLINE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT DISEASE; CHEMICAL COMPOSITION; COHORT ANALYSIS; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; GALLSTONE; HUMAN; IN VITRO STUDY; LIPID METABOLISM; MALE; METABOLIC PARAMETERS; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTIAL LEAST SQUARES REGRESSION; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; UNIVARIATE ANALYSIS; VATER PAPILLA STENOSIS;

EID: 77956905116     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00185.x     Document Type: Article

References (29)

1. Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A et al. (2001) Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 48:816-820.
2. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37:806-813.
3. Shaib Y, El-Serag HB. (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115-125.
4. Bjornsson E, Kilander A, Olsson R. (1999) CA19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 19:501-508. (Pubitemid 30019064)
5. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. (2000) The utility of CA19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 95:204-207.
6. Harewood GC, Baron TH, Stadheim LM, Kipp BR, Sebo TJ, Salomao DR. (2004) Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. Am J Gastroenterol 99:1464-1469.
7. Malhi H, Gores GJ. (2006) Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther 23:1287-1296.
8. Nicholson JK, Holmes E, Wilson ID. (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 3:431-438.
9. Cox IJ. (1988) Nuclear magnetic resonance spectroscopy. Br J Hosp Med 40:165.
10. Cox IJ, Sharif A, Cobbold JF, Thomas HC, Taylor-Robinson SD. (2006) Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease. World J Gastroenterol 12:4773-4783.
11. Khan SA, Cox IJ, Thillainayagam AV, Bansi DS, Thomas HC, Taylor- Robinson SD. (2005) Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. Eur J Gastroenterol Hepatol 17:733-738.
12. Bezabeh T, Ijare OB, Albiin N, Arnelo U, Lindberg B, Smith IC. (2009) Detection and quantification of D:-glucuronic acid in human bile using (1)H NMR spectroscopy: relevance to the diagnosis of pancreatic cancer. MAGMA 22:267-275.
13. Albiin N, Smith IC, Arnelo U, Lindberg B, Bergquist A, Dolenko B et al. (2008) Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis. Acta Radiol 49:855-862.
14. Alpini G, Glaser SS, Ueno Y, Rodgers R, Phinizy JL, Francis H et al. (1999) Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology 116:179-186.
15. Yoon JH, Higuchi H,Werneburg NW, Kaufmann SH, Gores GJ. (2002) Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. Gastroenterology 122:985-993.
16. Gowda GA, Ijare OB, Somashekar BS, Sharma A, Kapoor VK, Khetrapal CL. (2006) Single-step analysis of individual conjugated bile acids in human bile using 1H NMR spectroscopy. Lipids 41:591-603.
17. Westerhuis JA, de Jong S, Smilde AK. (2001) Direct orthogonal signal correction. Chemometr Intell Lab Syst 56:13-25.
18. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW et al. (2002) Rapid and non-invasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8:1439-1444.
19. Mahadevan S, Shah SL, Marrie TJ, Slupsky CM. (2008) Analysis of metabolomic data using support vector machines. Anal Chem 80:7562-7570.
20. Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE et al. (2009) Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol 104:1435-1444.
21. Ishikawa H, Nakashima T, Inaba K, Mitsuyoshi H, Nakajima Y, Sakamoto Y et al. (1999) Proton magnetic resonance assay of total and taurineconjugated bile acids in bile. J Lipid Res 40:1920-1924.
22. Ijare OB, Bezabeh T, Albiin N, Arnelo U, Bergquist A, Lindberg B et al. (2009) Absence of glycochenodeoxycholic acid (GCDCA) in human bile is an indication of cholestasis: a 1H MRS study. NMR Biomed 22:471-479.
23. Komichi D, Tazuma S, Nishioka T, Hyogo H, Chayama K. (2005) Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage. Free Radic Biol Med 39:1418-1427.
24. Trauner M, Fickert P, Wagner M. (2007) MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis 27:77-98.
25. Bernstein H, Bernstein C, Payne CM, Dvorak K. (2009) Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol 15:3329-3340.
26. Dixon RM. (1998) NMR studies of phospholipid metabolism in hepatic lymphoma. NMR Biomed 11:370-379.
27. van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P et al. (1996) MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87:507-517.
28. Mauad TH, van Nieuwkerk CM, Dingemans KP, Smit JJ, Schinkel AH, Notenboom RG et al. (1994) Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol 145:1237-1245.
29. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. (2005) Cholangiocarcinoma. Lancet 366:1303-1314